Results 251 to 260 of about 22,643,381 (355)

A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B [PDF]

open access: bronze, 1986
Michel Vidaud   +5 more
openalex   +1 more source

An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System

open access: yesThe Clinical Respiratory Journal, Volume 19, Issue 6, June 2025.
ABSTRACT Backgrounds Pulmonary embolism (PE) is a common disease and a common cause of death. However, it is currently unclear which clinically common drugs can lead to PE. Methods We collected, organized, and analyzed reports from the first quarter of 2018 to the fourth quarter of 2022.
Hang Chen   +11 more
wiley   +1 more source

Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review. [PDF]

open access: yesHematol Transfus Cell Ther
Prezotti AN   +6 more
europepmc   +1 more source

Hemophilia B with inhibitor: molecular analysis of the subtotal deletion of the factor IX gene [PDF]

open access: bronze, 1985
H. J. Hassan   +8 more
openalex   +1 more source

Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype. [PDF]

open access: yesHemasphere
Rodeghiero F   +25 more
europepmc   +1 more source

Studies of lymph nodes from patients with classical hemophilia [PDF]

open access: bronze, 1984
W.A. Andes   +4 more
openalex   +1 more source

Tympanostomy tubes in children with hemophilia a [PDF]

open access: bronze, 1984
Stephen L. Liston   +3 more
openalex   +1 more source

Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9 [PDF]

open access: yes, 2019
Curiel, David T   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy